Open | $3.030 |
Close | $2.900 |
Volume / Avg. | 10.930K / 54.111K |
Day Range | 2.867 - 3.070 |
52 Wk Range | 2.500 - 18.000 |
Market Cap | $3.729M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 0.19% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Avinger (NASDAQ: AVGR) through any online brokerage.
Other companies in Avinger’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Bluejay Diagnostics (NASDAQ:BJDX), Nexalin Technology (NASDAQ:NXL) and Venus Concept (NASDAQ:VERO).
The latest price target for Avinger (NASDAQ: AVGR) was reported by HC Wainwright & Co. on Friday, March 8, 2024. The analyst firm set a price target for 5.00 expecting AVGR to rise to within 12 months (a possible 81.72% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Avinger (NASDAQ: AVGR) is $2.7515 last updated March 18, 2024 at 4:40 PM EDT.
There are no upcoming dividends for Avinger.
Avinger’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Avinger.
Avinger is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.